COMP <GO>
COSM vs HKPD // RETURN ON INVESTED CAPITAL (ROIC)
Cosmos Health Inc. (NASDAQ) VS. Cellyan Biotechnology Co. Ltd (Class A) (NASDAQ) • 15-METRIC TALLY: COSM 2
— HKPD 0
■ METRIC PARITY
LAST: $0.28 (+11.45%) • MKT CAP: $27.9M
roic
-35.00%
LAST: $2.19 (+0.46%) • MKT CAP: $5.4M
roic
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COSM VS. HKPD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COSM | HKPD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -25.60% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -29.30% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 19.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.5 | 35.5 | +16.01 | COSM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.9M | $5.4M | $22.5M | COSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COSM REV | HKPD REV | COSM GROSS % | HKPD GROSS % | COSM FCF | HKPD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $65.3M | — | 12.1% | — | -$8.5M | — |
| FY 2024 | $54.4M | — | 7.9% | — | -$8.1M | — |
| FY 2023 | $53.4M | — | — | — | -$15.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COSM // BETA —
HKPD // BETA —